-
Sector Analysis
Denmark Statutory and Private Employee Benefits, 2024 Update
Denmark Statutory and Private Employee Benefits Report Overview Danish social security operates a societal model in which the state assumes primary responsibility for the welfare of its citizens. It covers benefits such as hospitalization, sickness, and maternity benefits; benefits regarding accidents at work and occupational diseases; funeral expenses; disability pension; old-age and supplementary pensions; family benefits; and unemployment benefits. Denmark is among the few countries in the world, which adjusted to the challenge of providing its citizens with a flexible...
-
Sector Analysis
NewCzech Republic Statutory and Private Employee Benefits, 2024 Update
Czech Republic Statutory and Private Employee Benefits Report Overview The Czech Republic has a well-developed social security system. Employers, employees, and self-employed people contribute to the social security schemes. The country’s social security system is built on three pillars: compulsory social insurance, state social support system, and social assistance. Compulsory social insurance covers pension insurance, health insurance, and the national employment policy system. The non-contributory state social support system supports families with dependent children. The final pillar, tax-financed social assistance,...
-
Sector Analysis
Romania Statutory and Private Employee Benefits, 2024 Update
Romania Statutory and Private Employee Benefits Overview Romania has a well-established social security system. To provide its citizens with decent living conditions, the Romanian government provides various social security schemes in close association with private institutions. The Romanian pension system is divided into four pillars – the first is a mandatory public pension system, which functions as a pay-as-you-go (PAYG) system. Privately administered pension fund schemes form the second pillar, voluntary occupational pension schemes form the third pillar, and private...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Lennox-Gastaut Syndrome Drug Details: JBPOS-0101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Alzheimer's Disease Drug Details: JBPOS-0101 is under development for the...
-
Sector Analysis
Bulgaria Statutory and Private Employee Benefits, 2024 Update
Bulgaria Statutory and Private Employee Benefits Report Overview The National Social Security Institute (NSSI) is responsible for managing all the social security schemes in the Republic of Bulgaria. It administers mandatory social security schemes such as sickness, maternity, occupational diseases, workplace accidents, disability, old age, and survivor’s pensions. Irrespective of whether a person is employed, unemployed, or self-employed, Bulgarians are covered under certain social security schemes. The Bulgaria employee benefits report provides an in-depth industry analysis, information, and insights into...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-996 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-996 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-996 in Type 2 Diabetes Drug Details: CT-996 (RG6652) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deuterated Etifoxine in Post Partum Depression (Maternal Depression / Postnatal Depression)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated Etifoxine in Post Partum Depression (Maternal Depression / Postnatal Depression) Drug Details: Deuterated etifoxine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GH-001 in Post Partum Depression (Maternal Depression / Postnatal Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GH-001 in Post Partum Depression (Maternal Depression / Postnatal Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GH-001 in Post Partum Depression (Maternal Depression...